{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:57:39Z","timestamp":1785772659127,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003969","name":"Ministry of Health and Medical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.intimp.2023.110217","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T04:47:43Z","timestamp":1682311663000},"page":"110217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of the MCP-1-2518A>G polymorphism on COVID-19 severity in the Iranian population: A case-control study"],"prefix":"10.1016","volume":"119","author":[{"given":"Niki Ghambari","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Namaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahmoud","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ghaffarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-7095","authenticated-orcid":false,"given":"Tooba","family":"Ghazanfari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2023.110217_b0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110217_b0010","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/s41467-020-16256-y","article-title":"A human monoclonal antibody blocking SARS-CoV-2 infection","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2023.110217_b0015","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"issue":"10223","key":"10.1016\/j.intimp.2023.110217_b0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.intimp.2023.110217_b0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nri1732","article-title":"Immunopathogenesis of coronavirus infections: implications for SARS","volume":"5","author":"Perlman","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"Pt B","key":"10.1016\/j.intimp.2023.110217_b0030","article-title":"MCP-1: Function, regulation, and involvement in disease","volume":"101","author":"Singh","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110217_b0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110217_b0040","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144455","article-title":"An immune-based biomarker signature is associated with mortality in COVID-19 patients","volume":"6","author":"Abers","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.intimp.2023.110217_b0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12985-020-01478-9","article-title":"Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling","volume":"18","author":"Xi","year":"2021","journal-title":"Virol. J."},{"issue":"5","key":"10.1016\/j.intimp.2023.110217_b0050","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China","volume":"222","author":"Chi","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2023.110217_b0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110217_b0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"21","key":"10.1016\/j.intimp.2023.110217_b0065","doi-asserted-by":"crossref","first-page":"13795","DOI":"10.1073\/pnas.202357499","article-title":"HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels","volume":"99","author":"Gonzalez","year":"2002","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.intimp.2023.110217_b0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/geno.1994.1283","article-title":"The human MCP-3 gene (SCYA7): cloning, sequence analysis, and assignment to the C-C chemokine gene cluster on chromosome 17q11.2-q12","volume":"21","author":"Opdenakker","year":"1994","journal-title":"Genomics"},{"issue":"8","key":"10.1016\/j.intimp.2023.110217_b0075","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.105.543579","article-title":"CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study","volume":"112","author":"McDermott","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2023.110217_b0080","doi-asserted-by":"crossref","unstructured":"M. M\u00fchlbauer et al., A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease, Gastroenterology 125(4) (2003) 1085\u20131093, doi: 10.1016\/s0016-5085(03)01213-7 (in eng).","DOI":"10.1016\/S0016-5085(03)01213-7"},{"issue":"2","key":"10.1016\/j.intimp.2023.110217_b0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/QAI.0b013e31802b3147","article-title":"Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects","volume":"44","author":"Vilad\u00e9s","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"6","key":"10.1016\/j.intimp.2023.110217_b0090","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/emm.2006.82","article-title":"Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance","volume":"38","author":"Park","year":"2006","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.110217_b0095","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/JCM.44.5.1847-1850.2006","article-title":"Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation","volume":"44","author":"Loeffler","year":"2006","journal-title":"J. Clin. Microbiol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110217_b0100","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.20050126","article-title":"A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis","volume":"202","author":"Flores-Villanueva","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110217_b0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jinf.2015.03.006","article-title":"Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection","volume":"71","author":"Tu","year":"2015","journal-title":"J. Infect."},{"key":"10.1016\/j.intimp.2023.110217_b0110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijid.2022.06.030","article-title":"Host genetic loci LZTFL1 and CCL2 associated with SARS-CoV-2 infection and severity of COVID-19","volume":"122","author":"R\u00fcter","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.intimp.2023.110217_b0115","unstructured":"Geneva: World Health Organization, Clinical management of COVID-19: Living guideline, https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2023.1 (accessed 13 January 2023)."},{"key":"10.1016\/j.intimp.2023.110217_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103077","article-title":"High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients","volume":"62","author":"Yeregui","year":"2020","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.intimp.2023.110217_b0125","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.4238\/2015.April.27.18","article-title":"MCP-1 gene polymorphisms in North Chinese patients with pulmonary tuberculosis","volume":"14","author":"Shi","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"9","key":"10.1016\/j.intimp.2023.110217_b0130","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.neurobiolaging.2003.11.008","article-title":"MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels","volume":"25","author":"Fenoglio","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.intimp.2023.110217_b0135","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/bbrc.1999.0796","article-title":"A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression","volume":"259","author":"Rovin","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2023.110217_b0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s10020-020-00230-x","article-title":"IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19","volume":"26","author":"Chen","year":"2020","journal-title":"Mol. Med."},{"issue":"19","key":"10.1016\/j.intimp.2023.110217_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911338","article-title":"CXCL8, CCL2, and CMV seropositivity as new prognostic factors for a severe COVID-19 course","volume":"23","author":"Pius-Sadowska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2023.110217_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"13","key":"10.1016\/j.intimp.2023.110217_b0155","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"6","key":"10.1016\/j.intimp.2023.110217_b0160","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1473-3099(20)30232-2","article-title":"Viral dynamics in mild and severe cases of COVID-19","volume":"20","author":"Liu","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2023.110217_b0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110217_b0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4049\/jimmunol.2000413","article-title":"COVID-19 as an acute inflammatory disease","volume":"205","author":"Manjili","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110217_b0175","doi-asserted-by":"crossref","unstructured":"J. Garcia Borrega et al., In the eye of the storm: immune-mediated toxicities associated with CAR-T cell therapy, Hemasphere, 3(2) (2019) e191, doi: 10.1097\/hs9.0000000000000191 (in eng).","DOI":"10.1097\/HS9.0000000000000191"},{"key":"10.1016\/j.intimp.2023.110217_b0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2019.00055","article-title":"Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis","volume":"10","author":"Karakike","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110217_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102524","article-title":"Could Sars-coronavirus-2 trigger autoimmune and\/or autoinflammatory mechanisms in genetically predisposed subjects?","volume":"19","author":"Caso","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2023.110217_b0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine storms: understanding COVID-19","volume":"53","author":"Mangalmurti","year":"2020","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2023.110217_b0195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110217_b0200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41577-020-0312-7","article-title":"COVID-19: risk for cytokine targeting in chronic inflammatory diseases?","volume":"20","author":"Schett","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110217_b0205","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jiph.2020.07.014","article-title":"COVID-19 and comorbidities: deleterious impact on infected patients","volume":"13","author":"Ejaz","year":"2020","journal-title":"J. Infect. Public Health"},{"issue":"1","key":"10.1016\/j.intimp.2023.110217_b0210","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1038\/s41598-021-82862-5","article-title":"Causes of death and comorbidities in hospitalized patients with COVID-19","volume":"11","author":"Elezkurtaj","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2023.110217_b0215","first-page":"1684","article-title":"Predictors of morbidity and mortality in COVID-19","volume":"25","author":"Gacche","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2023.110217_b0220","doi-asserted-by":"crossref","unstructured":"C. Sardu, J. Gambardella, M.B. Morelli, X. Wang, R. Marfella, G. Santulli, Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence, J. Clin. Med. 9(5) (2020), doi: 10.3390\/jcm9051417 (in eng).","DOI":"10.3390\/jcm9051417"},{"issue":"8","key":"10.1016\/j.intimp.2023.110217_b0225","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol"},{"issue":"3","key":"10.1016\/j.intimp.2023.110217_b0230","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41569-020-00469-1","article-title":"Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation","volume":"18","author":"Gu","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"10234","key":"10.1016\/j.intimp.2023.110217_b0235","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2023.110217_b0240","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/his.14134","article-title":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction","volume":"77","author":"Menter","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.intimp.2023.110217_b0245","article-title":"Amplification-refractory mutation system (ARMS) analysis of point mutations","author":"Little","year":"2001","journal-title":"Curr. Protoc. Hum. Genet."},{"issue":"4","key":"10.1016\/j.intimp.2023.110217_b0250","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s10528-021-10041-2","article-title":"Association of eNOS and MCP-1 genetic variants with type 2 diabetes and diabetic nephropathy susceptibility: a case-control and meta-analysis study","volume":"59","author":"Raina","year":"2021","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.intimp.2023.110217_b0255","doi-asserted-by":"crossref","unstructured":"R. Zhang et al., SNP Cutter: a comprehensive tool for SNP PCR-RFLP assay design, (in eng), Nucleic Acids Res. 33(Web Server issue) (2005) W489\u2013W492, doi: 10.1093\/nar\/gki358 (in eng).","DOI":"10.1093\/nar\/gki358"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923005386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923005386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:29:19Z","timestamp":1785770959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923005386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":51,"alternative-id":["S1567576923005386"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110217","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the MCP-1-2518A>G polymorphism on COVID-19 severity in the Iranian population: A case-control study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110217"}}